Rafael Rotaeche
Grupo México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rafael Rotaeche.
Revista Española de Geriatría y Gerontología | 2018
Arritxu Etxeberria; Josune Iribar; Rafael Rotaeche; Kalliopi Vrotsou; Iosu Barral; Grupo de Polimedicación y Uso Prudente de Gipuzkoa; I. Barral; X. Etxeberria; M. Barandiaran; O. Frias; J.L. Garcés; I. Idarreta; J. Iribar; B. López; I. Makazaga; B. Morcillo; C. Mozo; Itziar Vergara; K. Vrotsou; X. Zubeldia
BACKGROUND AND OBJECTIVE Several interventions have been shown to reduce polypharmacy and potentially inappropriate prescription (PIP). The objective of the study was to evaluate the number of drugs and PIP before and after an educational intervention with the Primary Care physician (PCP), with electronic identification of PIP and structured medication review, in elderly patients with excessive polypharmacy (≥10 drugs). MATERIAL AND METHODS A before-after intervention study was conducted in the Gipuzkoa district of Osakidetza (Basque Country Health System), in a random sample of patients older than 80 years taking ≥ 10 drugs, and whose PCP attended training sessions. Primary outcomes: change in the number of drugs and PIP, registered in computerised health records. SECONDARY OUTCOMES benefit/risk ratio assessed by the PCP, safety problems, and therapeutic decision. RESULTS Of the 591 eligible patients, 88 were excluded (41: PCP did not attend training sessions, 47: death/transfer/admission), including a total of 503 patients with mean age of 84.9 years, with 67.7% women. The mean number of drugs and PIP per patient decreased significantly, -0.88 (95% CI: -1.04 to -0.72) and -0.19 (95% CI: -0.29 to -0.09), respectively (p<.0001), with a 25.8% reduction in the number of patients with excessive polypharmacy. SECONDARY OUTCOMES data collection sheets of 365 patients and 4,168 prescriptions were collected. The benefit-risk ratio was favourable for 75% of the prescriptions, with the most frequent decision being to maintain them (83%). Among the 911 prescriptions with an unfavourable/uncertain benefit/risk ratio, 47.3% were maintained. CONCLUSIONS The intervention is associated with a reduction in excessive polypharmacy and PPI under real-world conditions.
BMC Health Services Research | 2018
Arritxu Etxeberria; Idoia Alcorta; Itziar Pérez; José Ignacio Emparanza; Elena Ruiz de Velasco; Maria Teresa Iglesias; Rafael Rotaeche
BackgroundThe implementation of evidence-based clinical practice guidelines (CPG) can improve patients care. To date, the impact of implementation strategies has not been evaluated in our context. This study is aimed to evaluate the effectiveness of a multifaceted tailored intervention targeting clinician education for the implementation of three cardiovascular risk-related CPGs (type 2 diabetes, hypertension and dyslipidemia) in primary care at the Basque Health Service compared with usual implementation.MethodsWe conducted a cluster randomized controlled trial in two urban districts with 43 primary care units (PCU). Data from all patients diagnosed with diabetes, hypertension and all those eligible for coronary risk (CR) assessment were included.In the control group, guidelines were introduced in the usual way (by email, intranet and clinical meetings). In the intervention group, the implementation also included a specific website and workshops.Primary endpoints were annual HbA1c testing (diabetes), annual general laboratory testing (hypertension) and annual CR assessment (dyslipidemia). Secondary endpoints were process, prescription and clinical endpoints related with guideline recommendations. Analysis was performed at a PCU level weighted by cluster size.ResultsSignificant differences between groups were observed in primary outcomes in the dyslipidemia CPG: increased CR assessment for both women and men (weighted mean difference, WMD, 13.58 and 12.91%). No significant differences were observed in diabetes and hypertension CPGs primary outcomes. Regarding secondary endpoints, annual CR assessment was significantly higher in both diabetic and hypertensive patients in the intervention group (WMD 28.16 and 27.55%). Rates of CR assessment before starting new statin treatments also increased (WMD 23.09%), resulting in a lower rate of statin prescribing in low risk women. Diuretic prescribing was higher in the intervention group (WMD 20.59%). Clinical outcomes (HbA1c and blood pressure control) did not differ between groups.ConclusionsThe multifaceted implementation proved to be effective to increase the CR assessment and to improve prescription, but ineffective to improve diabetes and hypertension related outcomes. In order to obtain real improvements when cardiovascular issues are tackled, perhaps other or additional interventions need to be implemented besides education of professionals.Trial registrationCurrent Controlled Trials, ISRCTN 88876909 (retrospectively registered on January 13, 2009)
PLOS ONE | 2014
Ivan Solà; José Miguel Carrasco; Petra Díaz del Campo; Javier de Gracia; Carola Orrego; Flora Martínez; Anna Kotzeva; Imma Guillamón; Enrique Calderón; Idoia de Gaminde; Arturo Louro; Rafael Rotaeche; Flavia Salcedo; Paola Velázquez; Pablo Alonso-Coello
BMC Health Services Research | 2006
Carlos Calderón; Rafael Rotaeche; Arritxu Etxebarria; Mercé Marzo; Rosa Rico; Marta Barandiaran
Atencion Primaria | 2015
Andrea Juliana Sanabria; David Rigau; Rafael Rotaeche; Anna Selva; Mercè Marzo-Castillejo; Pablo Alonso-Coello
BMC Health Services Research | 2009
Pablo Alonso-Coello; Ivan Solà; Rafael Rotaeche; Ana Isabel González González; Mercè Marzo-Castillejo; Arturo Louro-González; Ricard Carrillo; Paola Velázquez; Guillermo García-Velasco; Carlos Calderón
BMC Health Services Research | 2013
Arritxu Etxeberria; Itziar Pérez; Idoia Alcorta; José Ignacio Emparanza; Elena Ruiz de Velasco; Maria Teresa Iglesias; Domingo Orozco-Beltrán; Rafael Rotaeche
BMC Family Practice | 2011
Carlos Calderón; Ivan Solà; Rafael Rotaeche; Mercè Marzo-Castillejo; Arturo Louro-González; Ricard Carrillo; Ana-Isabel González; Pablo Alonso-Coello
BMC Health Services Research | 2010
Anna Kotzeva; Ivan Solà; José Miguel Carrasco; Petra Díaz del Campo; Francisco Javier Gracia; E. Calderón; Idoia de Gaminde; Maria Dolors Estrada; Flora Martínez; Carola Orrego; Rafael Rotaeche; Flavia Salcedo; Paola Velázquez; Pablo Alonso-Coello
Atencion Primaria | 2011
Juan Antonio Sánchez Sánchez; Itziar Pérez Irazusta; Arritxu Etxeberria; M. Dolores Rivas; Antonio Montaño; Román Villegas; Mercè Marzo; P. Alonso; Ana Isabel González González; Guillermo García Velasco; Maite Martínez; Miguel Angel Mayer; Rafael Rotaeche